Longitudinal kinetics of human epididymis protein 4 in recurrent advanced ovarian carcinoma treated with platinum-based chemotherapy: mathematical modeling and prognostic implications.
Tracking early changes in ovarian cancer biomarker patterns during chemotherapy predicts treatment response better than single measurements alone.
Mathematical modeling of longitudinal HE4 kinetics during platinum-based chemotherapy in recurrent advanced ovarian carcinoma identifies early trajectory patterns with independent prognostic implications, enabling dynamic response monitoring beyond single-timepoint biomarker measurement. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- Multi-center retrospective cohort with mathematical kinetic modeling
- Category
- sentinel_scan
- Maturity
- Validated
- Journal
- International Journal of Gynecological Cancer
Why it surfaced
Novel quantitative kinetic biomarker approach in high-unmet-need recurrent ovarian cancer; multi-center data with mathematical modeling; Int J Gynecol Cancer publication from established gynecologic oncology group.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.